Oshima H - Search Results

1

Missense Mutant p53 Transactivates Wnt/β-Catenin Signaling in Neighboring p53-Destabilized Cells through the COX-2/PGE2 Pathway.

Nakayama M, Saito H, Murakami K, Oshima H, Oshima M. Nakayama M, et al. Among authors: oshima h. Cancer Res Commun. 2025 Jan 1;5(1):13-23. doi: 10.1158/2767-9764.CRC-24-0471. Cancer Res Commun. 2025. PMID: 39641656 Free PMC article.

2

Suppressing TGFβ signaling in regenerating epithelia in an inflammatory microenvironment is sufficient to cause invasive intestinal cancer.

Oshima H, Nakayama M, Han TS, Naoi K, Ju X, Maeda Y, Robine S, Tsuchiya K, Sato T, Sato H, Taketo MM, Oshima M. Oshima H, et al. Among authors: oshima m. Cancer Res. 2015 Feb 15;75(4):766-76. doi: 10.1158/0008-5472.CAN-14-2036. Cancer Res. 2015. PMID: 25687406

3

Loss of wild-type p53 promotes mutant p53-driven metastasis through acquisition of survival and tumor-initiating properties.

Nakayama M, Hong CP, Oshima H, Sakai E, Kim SJ, Oshima M. Nakayama M, et al. Among authors: oshima h, oshima m. Nat Commun. 2020 May 11;11(1):2333. doi: 10.1038/s41467-020-16245-1. Nat Commun. 2020. PMID: 32393735 Free PMC article.

4

Gain-of-Function p53 Mutation Acts as a Genetic Switch for TGFβ Signaling-Induced Epithelial-to-Mesenchymal Transition in Intestinal Tumors.

Wang D, Nakayama M, Hong CP, Oshima H, Oshima M. Wang D, et al. Among authors: oshima h, oshima m. Cancer Res. 2024 Jan 2;84(1):56-68. doi: 10.1158/0008-5472.CAN-23-1490. Cancer Res. 2024. PMID: 37851521 Free PMC article.

5

Combined Mutation of Apc, Kras, and Tgfbr2 Effectively Drives Metastasis of Intestinal Cancer.

Sakai E, Nakayama M, Oshima H, Kouyama Y, Niida A, Fujii S, Ochiai A, Nakayama KI, Mimori K, Suzuki Y, Hong CP, Ock CY, Kim SJ, Oshima M. Sakai E, et al. Among authors: oshima h, oshima m. Cancer Res. 2018 Mar 1;78(5):1334-1346. doi: 10.1158/0008-5472.CAN-17-3303. Epub 2017 Dec 27. Cancer Res. 2018. PMID: 29282223

6

Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin.

Harada N, Miyoshi H, Murai N, Oshima H, Tamai Y, Oshima M, Taketo MM. Harada N, et al. Among authors: oshima h, oshima m. Cancer Res. 2002 Apr 1;62(7):1971-7. Cancer Res. 2002. PMID: 11929813

7

Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations.

Harada N, Oshima H, Katoh M, Tamai Y, Oshima M, Taketo MM. Harada N, et al. Among authors: oshima h, oshima m. Cancer Res. 2004 Jan 1;64(1):48-54. doi: 10.1158/0008-5472.can-03-2123. Cancer Res. 2004. PMID: 14729607

8

Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice.

Oshima M, Oshima H, Matsunaga A, Taketo MM. Oshima M, et al. Among authors: oshima h. Cancer Res. 2005 Oct 15;65(20):9147-51. doi: 10.1158/0008-5472.CAN-05-1936. Cancer Res. 2005. PMID: 16230370

9

Induction of prostaglandin E2 pathway promotes gastric hamartoma development with suppression of bone morphogenetic protein signaling.

Oshima H, Itadani H, Kotani H, Taketo MM, Oshima M. Oshima H, et al. Among authors: oshima m. Cancer Res. 2009 Apr 1;69(7):2729-33. doi: 10.1158/0008-5472.CAN-08-4394. Epub 2009 Mar 24. Cancer Res. 2009. PMID: 19318548 Free article.

10

Prostaglandin E2, Wnt, and BMP in gastric tumor mouse models.

Oshima H, Oguma K, Du YC, Oshima M. Oshima H, et al. Among authors: oshima m. Cancer Sci. 2009 Oct;100(10):1779-85. doi: 10.1111/j.1349-7006.2009.01258.x. Epub 2009 Jun 23. Cancer Sci. 2009. PMID: 19622104 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,008 results

Search Page

Filters